Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | YDES YD Bio Limited | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $7.42 -2.5% | $16.31 +6.3% |
| StockIQ Score | 81A- Strong Risk: High | 42D Weak Risk: Medium |
| Technical | 83A- | 36F |
| Fundamental | — | 35F |
| Growth | — | 50C- |
| Fair Value | — | 38F |
| News | 100A+ | 50C- |
| Quality | — | 50C- |
| Risk | 34F | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
YD Bio Limited (YDES) outperforms Ascentage Pharma (AAPG) in nearly every category. Its investor score (81 vs. 42) and technical score (83 vs. 36) are significantly higher, while AAPG’s rating is "WEAK" compared to YDES’s "STRONG." Only AAPG’s growth score (50) is higher than YDES’s unavailable data, but the other metrics clearly favor YDES.
